levodopa has been researched along with Down Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dement'eva, NF; Ermolina, LA; Ezhkova, VA; Mozhaeva, EG | 1 |
| Beaulieu, I; Castells, S; Gelato, MC; Torrado, C; Wisniewski, KE; Zarny, S | 1 |
| Bergamaschi, R; Cacciari, E; Cicognani, A; Gualandi, S; Mazzanti, L; Nanni, S; Perri, A; Pirazzoli, P; Scarano, E; Zucchini, S | 1 |
| Giambi, C; Giuliano, S; Pallotti, S | 1 |
| Bastian, W; Castells, S; Torrado, C; Wisniewski, KE | 1 |
| Sanchez-Ramos, J; Singer, C; Weiner, WJ | 1 |
| Chase, TN | 1 |
2 review(s) available for levodopa and Down Syndrome
| Article | Year |
|---|---|
[Therapy and social adaptation of patients with mental retardation (a review of the literature)].
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebral Palsy; Child; Child, Preschool; Down Syndrome; Education of Intellectually Disabled; Humans; Infant; Intellectual Disability; Levodopa; Male; Phenylketonurias; Rehabilitation, Vocational; Social Adjustment | 1981 |
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extrapyramidal Tracts; Fenclonine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Imipramine; Levodopa; Muscular Diseases; Paralysis; Parkinson Disease; Parkinson Disease, Secondary; Probenecid; Reserpine; Serotonin; Spinal Cord Diseases; Tetrabenazine; Time Factors | 1974 |
5 other study(ies) available for levodopa and Down Syndrome
| Article | Year |
|---|---|
Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation.
Topics: Anthropometry; Child, Preschool; Clonidine; Down Syndrome; Dwarfism, Pituitary; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamic Diseases; Hypothalamo-Hypophyseal System; Infant; Levodopa; Male; Reference Values | 1996 |
Reduced spontaneous growth hormone secretion in patients with Turner's syndrome.
Topics: Adolescent; Age Determination by Skeleton; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Dopamine Agents; Down Syndrome; Electronic Data Processing; Female; Growth Disorders; Human Growth Hormone; Humans; Karyotyping; Levodopa; Male; Radioimmunoassay; Turner Syndrome; X Chromosome | 1999 |
[Growth disorders in Down's syndrome: growth hormone treatment].
Topics: Adult; Blood Glucose; Body Height; Down Syndrome; Drug Evaluation; Female; Follow-Up Studies; Glycated Hemoglobin; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Male; Pyridostigmine Bromide; Thyroid Hormones; Treatment Outcome | 2002 |
Growth hormone deficiency in Down's syndrome children.
Topics: Adolescent; Anthropometry; Child; Child, Preschool; Clonidine; Down Syndrome; Dwarfism, Pituitary; Female; Growth Hormone; Humans; Infant; Insulin-Like Growth Factor I; Levodopa; Male; Thyroid Hormones | 1992 |
Levodopa-responsive parkinsonism in a patient with Down's syndrome.
Topics: Activities of Daily Living; Carbidopa; Dose-Response Relationship, Drug; Down Syndrome; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease | 1990 |